AJP - Regu AJP: Lung Cellular and Molecular Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 285: R149-R154, 2003; doi:10.1152/ajpregu.00003.2003
0363-6119/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ross, J.
Right arrow Articles by Armstead, W. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ross, J.
Right arrow Articles by Armstead, W. M.

LOCAL CONTROL OF CIRCULATION

Differential role of PTK and ERK MAPK in superoxide impairment of KATP and KCa channel cerebrovasodilation

John Ross and William M. Armstead

Departments of Anesthesia and Pharmacology, University of Pennsylvania, Philadelphia, PA 19104

Submitted 6 January 2003 ; accepted in final form 24 March 2003

Previously, superoxide (O2 -) has been observed to impair pial artery dilation (PAD) to activators of the ATP-sensitive (KATP) and calcium-sensitive (KCa) K+ channels. This study tested the hypothesis that activation of protein tyrosine kinase (PTK) and the ERK isoform of MAPK by O2 - contribute to impairment of KATP and KCa channel PAD. Exposure of the cerebral cortex to a xanthine oxidase O2 --generating system (OX) blunted PAD to cromakalim, a KATP agonist, but preadministration of genistein, a PTK antagonist, or U-0126, an ERK MAPK inhibitor, almost completely prevented such impairment (11 ± 1 and 22 ± 1 vs. 3 ± 1 and 7 ± 1 vs. 10 ± 1 and 16 ± 2% for cromakalim with 10-8 and 10-6 M PAD during control, OX, and OX + genistein conditions). In contrast, neither genistein nor U-0126 robustly protected PAD to NS-1619, a KCa agonist, after OX exposure (11 ± 1 and 18 ± 2 vs. 1 ± 1 and 2 ± 1 vs. 4 ± 1 and 6 ± 1% for 10-8 and 10-6 M NS-1619 during control, OX, and OX + genistein conditions). These data show that PTK and ERK MAPK activation contribute to O2 --induced KATP and KCa channel PAD impairment and suggest a differential greater role for PTK and ERK MAPK in KATP vs. KCa channel PAD impairment.

oxygen free radicals; K+ channels; signal transduction



Address for reprint requests and other correspondence: W. M. Armstead, Dept. of Anesthesia, Univ. of Pennsylvania, 3400 Spruce St., Philadelphia, PA 19104 (E-mail: armsteaw{at}uphs.upenn.edu).




This article has been cited by other articles:


Home page
HypertensionHome page
H. Xu, X. Bian, S. W. Watts, and A. Hlavacova
Activation of Vascular BK Channel by Tempol in DOCA-Salt Hypertensive Rats
Hypertension, November 1, 2005; 46(5): 1154 - 1162.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. D. Gutterman, H. Miura, and Y. Liu
Redox Modulation of Vascular Tone: Focus of Potassium Channel Mechanisms of Dilation
Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 671 - 678.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.